Answer: Semaglutide is a GLP-1 receptor agonist, a prescription medication originally developed for type 2 diabetes and now FDA-approved for chronic weight management, given as a once-weekly injection that reduces appetite and slows digestion
Approved Uses of Semaglutide Semaglutide was first approved by the U.S
A small observational study published in the Journal of Clinical Endocrinology & Metabolism in 2023 noted a reduction in uterine volume in some women with fibroids who were taking GLP-1 receptor agonists like Ozempic
I think our Co-Founder/COO said it best: The "patient" has officially become a customer
Our comprehensive weight loss clinic near Bloomfield Hills, MI designed to provide you with effective, personalized solutions to achieve sustainable results
However, if any product comes back with a purity of less than 99%, we will provide a full refund, no questions asked